Cite

HARVARD Citation

    Whyte, M. et al. (2019). Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet. 7 (2), pp. 93-105. [Online]. 
  
Back to record